• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Neola Medical

0.71 SEK-21.11 %13.7. klo 18.29
Less than 1K followers

NEOLA

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-21.11 %
-15.48 %
+8.10 %
-29.99 %
-30.65 %
-69.37 %
-57.88 %
-78.57 %
-86.76 %

Neola Medical operates in the medical technology sector. The company focuses on neonatal care, where it develops medical equipment. Examples of products that the company provides to the healthcare sector include technical monitoring and follow-up of lung capacity in premature infants. In addition to the main product, ancillary products and disposables are offered. The largest operations are found in the Nordic market. Neola Medical was founded in 2016 and is headquartered in Sweden.

Read more
Market cap
78.44M SEK
Turnover
431.24K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
21.8.
2026

Interim report Q2'26

18.11.
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release10.06.2026 klo 08.30

Neola Medical granted Patent in the U.S. for reducing optical noise in lung monitoring measurements

Neola Medical
Press release03.06.2026 klo 08.30

Neola Medical to Present at Aktiedagarna: Advancing U.S. Market Preparations Following Positive Clinical Safety Results

Neola Medical
Press release20.05.2026 klo 12.20

Redeye: Neola Medical (Q1 Review): An undramatic report after an eventful period

Neola Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release19.05.2026 klo 08.00

Neola Medical Q1 Report 2026 – Positive safety results from clinical study in preterm born babies strengthen the path toward market

Neola Medical
Regulatory press release21.04.2026 klo 08.00

Neola Medical Reports Positive Safety Results from First Clinical Pilot Study and Advances Towards Next Phase of Clinical Development

Neola Medical
Press release16.03.2026 klo 08.05

Neola Medical Completes Enrollment in Swedish Clinical Pilot Study

Neola Medical
Press release13.02.2026 klo 13.59

Redeye: Neola Medical (Q4 Review): Eyes on upcoming clinical data

Neola Medical
Regulatory press release12.02.2026 klo 08.00

Neola Medical Q4 Report 2025 – Advancing IP Protection as a Core Strategic Asset across Key Markets

Neola Medical
Press release05.02.2026 klo 09.00

Neola Medical invites to presentation of the Q4-report 2025

Neola Medical
Press release17.12.2025 klo 12.40

Neola Medical’s CEO shares recent company highlights in winter 2025 investor letter

Neola Medical
Regulatory press release09.12.2025 klo 08.00

Neola Medical expands leadership team with appointment of Director Disposable Product Development

Neola Medical
Press release02.12.2025 klo 08.00

Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market

Neola Medical
Press release13.11.2025 klo 08.00

Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements

Neola Medical
Press release07.11.2025 klo 09.37

Redeye: Neola Medical (Q3 Review) - Revised timeline

Neola Medical
Regulatory press release04.11.2025 klo 19.57

Neola Medical Q3 Report 2025 – Progressing toward completion of Swedish clinical pilot study and strengthening leadership team

Neola Medical
Regulatory press release04.11.2025 klo 19.53

Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola®

Neola Medical
Press release16.10.2025 klo 09.00

Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola®

Neola Medical
Press release01.10.2025 klo 08.00

Neola Medical’s CEO highlights recent progress in autumn 2025 investor letter

Neola Medical
Regulatory press release25.09.2025 klo 08.20

Neola Medical strengthens leadership team with appointment of Clinical Director

Neola Medical
Press release10.09.2025 klo 08.00

Neola Medical granted European patent enabling lung monitoring beyond preterm born babies

Neola Medical